GlassScriptPhysician profile
Kurtis N Stemple
NPI 1518907179
$20,939.31
in general payments reported to CMS, 2019-2025
9 companies · $2,499 in 2025
The $2,499 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,778 · 2020: $3,069 · 2021: $3,226 · 2022: $2,797 · 2023: $2,049 · 2024: $1,522 · 2025: $2,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,448 · Food and Beverage: $2,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,447.52 |
| Food and Beverage | $2,622.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $12,122.07 | 2019-2025 | |
| Rock Medical Orthopedics, INC. | $4,993.65 | 2019-2024 | |
| Stryker Corporation | $1,847.54 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Triathlon |
| Exactech, INC. | $984.17 | 2020 | |
| Nexus Medical Technologies LLC | $849.75 | 2025 | |
| Zimmer Biomet Holdings, INC. | $67.00 | 2025 | Identity |
| Smith+Nephew, INC. | $27.41 | 2024 | Journey II |
| Depuy Synthes Sales INC. | $25.68 | 2025 | Truespan Orthocord, Dynacord |
| Bioventus LLC | $22.04 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurtis Stemple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.